share_log

Cantor Fitzgerald Reiterates Neutral on TherapeuticsMD, Announces $1 Price Target

Cantor Fitzgerald Reiterates Neutral on TherapeuticsMD, Announces $1 Price Target

坎託·菲茨傑拉德重申對TherapeuticSMD持中立態度,宣佈1美元的目標股價
Benzinga Real-time News ·  2022/07/13 08:20

Cantor Fitzgerald analyst Louise Chen reiterates TherapeuticsMD (NASDAQ:TXMD) with a Neutral and announces $1 price target.

Cantor Fitzgerald分析師Louise Chen重申TreateuticsMD(納斯達克:TXMD)的中性,並宣佈1美元的目標價。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論